ID   GM03589
AC   CVCL_W024
SY   GM 3589
DR   CLO; CLO_0017211
DR   BioSample; SAMN00808463
DR   Coriell; GM03589
DR   Wikidata; Q54838146
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=3926002; DOI=10.1016/0005-2760(85)90115-8;
RA   Kobayashi T., Shinnoh N., Goto I., Kuroiwa Y., Okawauchi M.,
RA   Sugihara G., Tanaka M.;
RT   "Galactosylceramide- and lactosylceramide-loading studies in cultured
RT   fibroblasts from normal individuals and patients with globoid cell
RT   leukodystrophy (Krabbe's disease) and GM1-gangliosidosis.";
RL   Biochim. Biophys. Acta 835:456-464(1985).
//